The United States has lost its measles elimination status for the first time since 2000 after a regional review found sustained transmission amid falling childhood vaccination rates.
The Pan American Health Organization (PAHO) announced the decision Nov. 17, confirming an outcome anticipated before the formal finding. Bolivia and Mexico also lost their designations in the review.
An independent regional commission traced the U.S. chain of infections to Jan. 20, 2025. The chain lasted more than 12 months, exceeding the threshold for re-established endemic transmission. PAHO Director Jarbas Barbosa accepted the commission’s recommendation to withdraw the designation.
The Centers for Disease Control and Prevention (CDC) counted 5,412 confirmed U.S. cases in 2026 as of Nov. 12, more than double the 2,289 recorded in all of 2025. Both counts are preliminary. The CDC said 96% of this year’s cases were associated with outbreaks.
Elimination does not mean every case has disappeared. A country can retain the designation after an imported case if sustained local transmission does not take hold. The decision concerns measles; U.S. elimination status for rubella and congenital rubella syndrome is unchanged.
CDC data show that coverage with the measles, mumps and rubella vaccine among U.S. kindergartners fell to 92.4% in the 2025–2026 school year from 95.2% in 2019–2020. PAHO says vaccination gaps increase risks for infants awaiting vaccination and people who cannot be vaccinated because of medical conditions.
“The measles elimination designation is not what protects Americans. Vaccination does,” CDC Director Erica Schwartz said. The agency said it has provided about $100 million in additional funding since August for work on measles and other vaccine-preventable diseases through most of 2027.
Brazil regained measles elimination status in 2024, a precedent PAHO cited in its technical guidance. To regain the designation, the United States must document at least 12 consecutive months without endemic transmission and provide evidence of stronger vaccination, surveillance and outbreak response. PAHO has also required a corrective action plan.


